Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation elongation factor 1 alpha 1 pseudogene 32 (EEF1A1P32) is an unprocessed pseudogene located at chromosome 1q31.3 in humans[2]. It is one of many pseudogenes derived from the EEF1A1 gene, which encodes a subunit of the elongation factor-1 complex involved in the translation elongation step of protein biosynthesis. As a pseudogene, EEF1A1P32 contains DNA sequences similar to the functional EEF1A1 gene but is not believed to produce a functional protein. Most EEF1A1 pseudogenes have arisen via retrotransposition or gene duplication and do not encode proteins, though some pseudogene transcripts may have regulatory roles. EEF1A1P32 itself has been cited in genomic studies of certain cancers, such as oral squamous cell carcinoma, but its biological or clinical significance remains unclear[2][1]. It is not considered a drug target, receptor, enzyme, or direct biomarker for disease[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 32 (EEF1A1P32).